Our study further supports this notion that human SMAD4 enhances the cytotoxicity of NK cells, at least in part by upregulating YTHDF2 expression, thereby inhibiting the survival and proliferating of CRC cells. The gene discussed is YTHDF2; the disease is colorectal carcinoma.